Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

2.

A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer.

Vadell-Nadal C, Nogué-Aliguer M, Fabregat-Mayol X, Saigí-Grau E, Gallén-Castillo M.

Lung Cancer. 2000 May;28(2):109-15.

PMID:
10717328
3.

[Yield of diagnostic tests in neoplasms of unknown origin. A retrospective study].

Gil Gil M, Vadell Nadal C, Fabregat Mayol X, Tusquets Trias de Bes I, Nogué Aliguer M.

Rev Clin Esp. 1990 Apr;186(6):252-8. Spanish.

PMID:
2118269
4.

[Neuropathy of the chin associated with neoplasms. Presentation of 5 cases and a review of the literature].

Vadell Nadal C, Tusquets Trías de Bes I, Roquer González J, Corominas Torres JM, Nogué Aliguer M, Gil Gil M, Fabregat Mayol X.

Arch Neurobiol (Madr). 1989 Jan-Feb;52(1):17-22. Review. Spanish.

PMID:
2541669
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk